A double-blind comparison of 0.25% and 0.05% desoxymethasone, 0.1% betamethasone valerate and 1% hydrocortisone creams in the treatment of eczema.
R E Ashton, M Catterall, N Morley, G Fairris, D N Joseph
Index: J. Int. Med. Res. 15(3) , 160-6, (1987)
Full Text: HTML
Abstract
The efficacy and acceptability of 0.25% and 0.05% desoxymethasone, 0.1% betamethasone valerate and 1% hydrocortisone creams were compared in patients with eczema. A double-blind parallel group multi-centre design was employed in which 96 patients were recruited by four centres. Patients used one cream for a 3-week period and follow-up assessment visits were made at weekly intervals. Efficacy variables were: erythema/redness, scaling, itching and extent of area affected. These variables were assessed by both the investigator and the patient. The 0.25% desoxymethasone was the most effective treatment, producing the greatest degree of improvement in all clinical parameters, hydrocortisone was the least effective and 0.05% desoxymethasone was of intermediate effectiveness. The 0.1% betamethasone produced similar results to 0.25% desoxymethasone for half the assessments; for the other half the results were similar to 0.05% desoxymethasone. No adverse effects were reported during the study. The results are discussed in terms of physical properties of the vehicles and corticosteroid potency.
Related Compounds
Related Articles:
2014-06-01
[Mol. Carcinog. 53(6) , 488-97, (2014)]
Photosensitivity to desoximetasone emollient cream.
1988-12-01
[Arch. Dermatol. 124(12) , 1870-1, (1988)]
1994-01-01
[Acta Derm. Venereol. 74(1) , 18-9, (1994)]
2008-01-01
[Skin Pharmacol. Physiol. 21(3) , 181-7, (2008)]
Spectrophotometric determination of desoximetasone in ointment using 1,4-dihydrazinophthalazine.
1996-06-01
[J. Pharm. Biomed. Anal. 14(8-10) , 947-50, (1996)]